Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Enanta Pharmaceuticals Inc banner

Enanta Pharmaceuticals Inc
SWB:9EP

Watchlist Manager
Enanta Pharmaceuticals Inc Logo
Enanta Pharmaceuticals Inc
SWB:9EP
Watchlist
Price: 11.9 EUR Market Closed
Market Cap: €1.4B
Write Note Create Alert Ask AI

Wall St Price Targets

9EP Price Targets Summary
Enanta Pharmaceuticals Inc

Wall Street analysts forecast 9EP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 9EP is 21.11 EUR with a low forecast of 18.31 EUR and a high forecast of 30.45 EUR.

9EP Lowest Forecast
Wall Street Target
€18.31
54% Upside
9EP Average Forecast
Wall Street Target
€21.11
77% Upside
9EP Highest Forecast
Wall Street Target
€30.45
156% Upside
Lowest Forecast
Price Target
18.31 EUR
54% Upside
Average Forecast
Price Target
21.11 EUR
77% Upside
Highest Forecast
Price Target
30.45 EUR
156% Upside
Enanta Pharmaceuticals Inc Competitors:
Price Targets
CDNA
CareDx Inc
-8% Downside
HCAT
Health Catalyst Inc
44% Upside
CDNA
CareDx Inc
-8% Downside
HCAT
Health Catalyst Inc
44% Upside

Revenue
Forecast

4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 24%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Continue 9EP Research

Summary
9EP intrinsic value, competitors valuation, and company profile.
DCF Valuation
9EP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
9EP stock valuation using valuation multiples.
Wall St Estimates
9EP price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
9EP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Enanta Pharmaceuticals Inc listings:
NASDAQ • USD
ENTA
 F • EUR
9EP
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 9EP's stock price target?
Price Target
21.11 EUR

According to Wall Street analysts, the average 1-year price target for 9EP is 21.11 EUR with a low forecast of 18.31 EUR and a high forecast of 30.45 EUR.

What is the Revenue forecast for Enanta Pharmaceuticals Inc?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join 354,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett